|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,229.00 INR | -1.02% |
|
+1.84% | -2.56% |
| 01/04 | Avendus Spark Upgrades Divi's Laboratories to Reduce from Sell, Price Target is INR5,840 | MT |
| 12/02 | Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.79TCr | |||||
| 83TCr | |||||
| 56TCr | |||||
| 37TCr | |||||
| 33TCr | - | ||||
| 32TCr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition